Glaukos Corporation
GKOS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 4.06 | -11.96 | 1.65 | -1.15 |
| FCF Yield | -0.25% | 0.10% | -0.37% | -0.01% |
| EV / EBITDA | -8,177.52 | -681.46 | -757.00 | -370.70 |
| Quality | ||||
| ROIC | -1.82% | -2.53% | -2.35% | -2.97% |
| Gross Margin | 78.41% | 78.33% | 77.20% | 72.86% |
| Cash Conversion Ratio | 0.62 | -0.36 | 1.02 | -0.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.67% | 13.41% | 11.85% | 10.68% |
| Free Cash Flow Growth | -302.16% | 128.35% | -1,568.76% | 88.89% |
| Safety | ||||
| Net Debt / EBITDA | -10.65 | -0.49 | 1.19 | 2.97 |
| Interest Coverage | -2.82 | -19.71 | -17.78 | -18.24 |
| Efficiency | ||||
| Inventory Turnover | 0.45 | 0.42 | 0.41 | 0.50 |
| Cash Conversion Cycle | 203.80 | 230.62 | 221.86 | 192.16 |